• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症及炎性小体在骨髓增殖性疾病中的作用

The Role of Inflammation and Inflammasome in Myeloproliferative Disease.

作者信息

Longhitano Lucia, Li Volti Giovanni, Giallongo Cesarina, Spampinato Mariarita, Barbagallo Ignazio, Di Rosa Michelino, Romano Alessandra, Avola Roberto, Tibullo Daniele, Palumbo Giuseppe Alberto

机构信息

Section of Biochemistry, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.

Department of Scienze Mediche Chirurgiche e Tecnologie Avanzate "G.F. Ingrassia", University of Catania, 95123 Catania, Italy.

出版信息

J Clin Med. 2020 Jul 22;9(8):2334. doi: 10.3390/jcm9082334.

DOI:10.3390/jcm9082334
PMID:32707883
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7464195/
Abstract

Polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF) are rare hematological conditions known as myeloproliferative neoplasms (MPNs). They are characterized for being negative malignancies and affected patients often present with symptoms which can significantly impact their quality of life. MPNs are characterized by a clonal proliferation of an abnormal hematopoietic stem/progenitor cell. In MPNs; cells of all myeloid lineages; including those involved in the immune and inflammatory response; may belong to the malignant clone thus leading to an altered immune response and an overexpression of cytokines and inflammatory receptors; further worsening chronic inflammation. Many of these cytokines; in particular, IL-1β and IL-18; are released in active form by activating the inflammasome complexes which in turn mediate the inflammatory process. Despite this; little is known about the functional effects of stem cell-driven inflammasome signaling in MPN pathogenesis. In this review we focused on the role of inflammatory pathway and inflammasome in MPN diseases. A better understanding of the inflammatory-state-driving MPNs and of the role of the inflammasome may provide new insights on possible therapeutic strategies.

摘要

真性红细胞增多症(PV)、原发性血小板增多症(ET)和原发性骨髓纤维化(PMF)是罕见的血液疾病,被称为骨髓增殖性肿瘤(MPN)。它们的特征是为阴性恶性肿瘤,患病患者常出现会显著影响其生活质量的症状。MPN的特征是异常造血干/祖细胞的克隆性增殖。在MPN中,所有髓系谱系的细胞,包括参与免疫和炎症反应的细胞,可能都属于恶性克隆,从而导致免疫反应改变以及细胞因子和炎症受体的过度表达,进一步加重慢性炎症。许多这些细胞因子,特别是白细胞介素-1β(IL-1β)和白细胞介素-18(IL-18),通过激活炎性小体复合物以活性形式释放,而炎性小体复合物反过来介导炎症过程。尽管如此,关于干细胞驱动的炎性小体信号在MPN发病机制中的功能作用知之甚少。在本综述中,我们重点关注炎症途径和炎性小体在MPN疾病中的作用。更好地了解驱动MPN的炎症状态以及炎性小体的作用可能为潜在的治疗策略提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70be/7464195/5bbbdf2fcf40/jcm-09-02334-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70be/7464195/c44fd83717e6/jcm-09-02334-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70be/7464195/5b2f6338aaa2/jcm-09-02334-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70be/7464195/5bbbdf2fcf40/jcm-09-02334-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70be/7464195/c44fd83717e6/jcm-09-02334-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70be/7464195/5b2f6338aaa2/jcm-09-02334-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70be/7464195/5bbbdf2fcf40/jcm-09-02334-g003.jpg

相似文献

1
The Role of Inflammation and Inflammasome in Myeloproliferative Disease.炎症及炎性小体在骨髓增殖性疾病中的作用
J Clin Med. 2020 Jul 22;9(8):2334. doi: 10.3390/jcm9082334.
2
Recent advances in understanding myelofibrosis and essential thrombocythemia.骨髓纤维化和原发性血小板增多症认识方面的最新进展。
F1000Res. 2016 Apr 19;5. doi: 10.12688/f1000research.8081.1. eCollection 2016.
3
Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms.炎性发病机制作为骨髓增殖性肿瘤的一个致病因素。
Front Immunol. 2021 Jun 1;12:683401. doi: 10.3389/fimmu.2021.683401. eCollection 2021.
4
Novel therapeutic strategies for essential thrombocythemia/polycythemia vera.原发性血小板增多症/真性红细胞增多症的新型治疗策略
Blood Res. 2023 Apr 30;58(S1):83-89. doi: 10.5045/br.2023.2023013.
5
Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.费城染色体阴性骨髓增殖性肿瘤的临床表现及并发症危险因素
Asian Pac J Cancer Prev. 2015;16(12):5013-8. doi: 10.7314/apjcp.2015.16.12.5013.
6
Classical Philadelphia-negative myeloproliferative neoplasms (MPNs): A continuum of different disease entities.经典费城阴性骨髓增殖性肿瘤(MPNs):一系列不同的疾病实体。
Int Rev Cell Mol Biol. 2021;365:1-69. doi: 10.1016/bs.ircmb.2021.09.001. Epub 2021 Sep 28.
7
Role of Inflammatory Factors during Disease Pathogenesis and Stem Cell Transplantation in Myeloproliferative Neoplasms.炎症因子在骨髓增殖性肿瘤疾病发病机制及干细胞移植中的作用
Cancers (Basel). 2020 Aug 12;12(8):2250. doi: 10.3390/cancers12082250.
8
Myeloproliferative Neoplasms in Children.儿童骨髓增殖性肿瘤
J Hematop. 2015 Sep;8(3):143-157. doi: 10.1007/s12308-015-0256-1. Epub 2015 Aug 2.
9
Role of Next Generation Immune Checkpoint Inhibitor (ICI) Therapy in Philadelphia Negative Classic Myeloproliferative Neoplasm (MPN): Review of the Literature.新一代免疫检查点抑制剂(ICI)疗法在费城阴性经典骨髓增殖性肿瘤(MPN)中的作用:文献综述
Int J Mol Sci. 2023 Aug 7;24(15):12502. doi: 10.3390/ijms241512502.
10
BCR::ABL1 negative myeloproliferative neoplasms: A review focused on essential thrombocythemia and polycythemia vera.BCR::ABL1 阴性骨髓增殖性肿瘤:以原发性血小板增多症和真性红细胞增多症为重点的综述。
Physiol Int. 2023 Aug 31;110(3):227-250. doi: 10.1556/2060.2023.00261. Print 2023 Sep 5.

引用本文的文献

1
Management of Myeloproliferative Neoplasms: An Integrative Approach.骨髓增殖性肿瘤的管理:一种综合方法。
J Clin Med. 2025 Jul 17;14(14):5080. doi: 10.3390/jcm14145080.
2
DNA Methylation in Ph-Negative Myeloproliferative Neoplasms: Prognostic Role and Therapeutic Implications.阴性骨髓增殖性肿瘤中的DNA甲基化:预后作用及治疗意义
Curr Issues Mol Biol. 2025 Mar 26;47(4):227. doi: 10.3390/cimb47040227.
3
Ruxolitinib stopped before transplantation does not induce cytokine release in myelofibrosis.在移植前停用的芦可替尼不会在骨髓纤维化中诱导细胞因子释放。

本文引用的文献

1
Cytokines frequently implicated in myeloproliferative neoplasms.细胞因子经常与骨髓增殖性肿瘤有关。
Cytokine X. 2019 Mar 27;1(1):100005. doi: 10.1016/j.cytox.2019.100005. eCollection 2019 Mar.
2
The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers.NLRP3 炎性体:炎症相关癌症的治疗靶点。
Expert Rev Clin Immunol. 2020 Feb;16(2):175-187. doi: 10.1080/1744666X.2020.1713755. Epub 2020 Jan 22.
3
Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib.芦可替尼抗炎和免疫抑制活性的潜在机制。
Cancer Immunol Immunother. 2025 Apr 24;74(6):181. doi: 10.1007/s00262-025-04046-8.
4
Dibenzo [a, c] phenazin-11-yl(phenyl) methanone (SBLJ23), a novel selective inhibitor targeting JAK2 mutation in myeloproliferative neoplasms.二苯并[a,c]吩嗪-11-基(苯基)甲酮(SBLJ23),一种靶向骨髓增殖性肿瘤中JAK2突变的新型选择性抑制剂。
Oncol Res. 2025 Feb 28;33(3):675-685. doi: 10.32604/or.2024.056256. eCollection 2025.
5
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis.乳酸积累促进骨髓纤维化中骨髓微环境的免疫抑制和纤维化转变。
J Transl Med. 2025 Jan 14;23(1):69. doi: 10.1186/s12967-025-06083-4.
6
Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis Patients.靶向代谢组学揭示原发性骨髓纤维化患者血清中抗氧化剂显著消耗、氧化/亚硝化应激增加以及嘌呤和嘧啶浓度改变。
Antioxidants (Basel). 2024 Apr 19;13(4):490. doi: 10.3390/antiox13040490.
7
CXCL8 and its cognate receptors CXCR1/CXCR2 in primary myelofibrosis.原发性骨髓纤维化中的 CXCL8 及其同源受体 CXCR1/CXCR2。
Haematologica. 2024 Jul 1;109(7):2060-2072. doi: 10.3324/haematol.2023.284921.
8
Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers.骨髓基质细胞在血液系统恶性肿瘤骨髓微环境重塑中的作用。
Biomolecules. 2023 Nov 24;13(12):1701. doi: 10.3390/biom13121701.
9
Philadelphia chromosome-negative myeloproliferative chronic neoplasms: is clonal hematopoiesis the main determinant of autoimmune and cardio-vascular manifestations?费城染色体阴性骨髓增殖性慢性肿瘤:克隆性造血是自身免疫和心血管表现的主要决定因素吗?
Front Med (Lausanne). 2023 Oct 17;10:1254868. doi: 10.3389/fmed.2023.1254868. eCollection 2023.
10
Putative Role of Neutrophil Extracellular Trap Formation in Chronic Myeloproliferative Neoplasms.中性粒细胞胞外诱捕网形成在慢性骨髓增殖性肿瘤中的推测作用。
Int J Mol Sci. 2023 Feb 24;24(5):4497. doi: 10.3390/ijms24054497.
Front Oncol. 2019 Nov 7;9:1186. doi: 10.3389/fonc.2019.01186. eCollection 2019.
4
Inhibition of NLRP3 inflammasome in tumor microenvironment leads to suppression of metastatic potential of cancer cells.肿瘤微环境中 NLRP3 炎性小体的抑制导致癌细胞转移潜能的抑制。
Sci Rep. 2019 Aug 22;9(1):12277. doi: 10.1038/s41598-019-48794-x.
5
The role of inflammasomes in kidney disease.炎症小体在肾脏疾病中的作用。
Nat Rev Nephrol. 2019 Aug;15(8):501-520. doi: 10.1038/s41581-019-0158-z.
6
The Role of New Technologies in Myeloproliferative Neoplasms.新技术在骨髓增殖性肿瘤中的作用
Front Oncol. 2019 Apr 26;9:321. doi: 10.3389/fonc.2019.00321. eCollection 2019.
7
Simultaneous Activation of Mu and Delta Opioid Receptors Reduces Allodynia and Astrocytic Connexin 43 in an Animal Model of Neuropathic Pain.同时激活μ阿片受体和δ阿片受体可减轻神经病理性疼痛动物模型的痛觉过敏和星形胶质细胞连接蛋白 43。
Mol Neurobiol. 2019 Nov;56(11):7338-7354. doi: 10.1007/s12035-019-1607-1. Epub 2019 Apr 28.
8
Inflammasomes in neuroinflammatory and neurodegenerative diseases.炎症小体与神经炎症和神经退行性疾病。
EMBO Mol Med. 2019 Jun;11(6). doi: 10.15252/emmm.201810248.
9
Diverging inflammasome signals in tumorigenesis and potential targeting.在肿瘤发生和潜在靶向中分歧的炎症小体信号。
Nat Rev Cancer. 2019 Apr;19(4):197-214. doi: 10.1038/s41568-019-0123-y.
10
Inflammasomes: Emerging Central Players in Cancer Immunology and Immunotherapy.炎症小体:癌症免疫学和免疫治疗中的新兴核心参与者。
Front Immunol. 2018 Dec 20;9:3028. doi: 10.3389/fimmu.2018.03028. eCollection 2018.